NCP-73601-02440
2 vaccinations
2 coded responses
19 check-ins
2 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 631 / MO
- Registered
- 2022-06-29
- Relationship
- Child or adolescent in my care
- Guardian
- VRC-11721-41867
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-29
Registered in v-safe
-
2022-06-29
Dose 1 — Moderna
- 2022-06-29
-
2022-06-30
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Irritability/crying, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesUnder 3 check-in
- 2022-07-01
-
2022-07-02
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-07-03
- 2022-07-04
- 2022-07-11
- 2022-07-13
-
2022-07-20
Survey response — day 21, dose 1, under 3MedDRA: Cough, Fatigue, Lymphadenopathy, Pyrexia, Viral infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Viral illness - high fever, fatigue, swollen lymph nodes, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-07-20
Report sent to call center — day 21, dose 1, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-07-21
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-07-27
Dose 2 — Moderna
- 2022-07-28
- 2022-07-29
- 2022-07-30
- 2022-07-31
- 2022-08-01
- 2022-08-02
- 2022-08-03
- 2022-08-10
- 2022-08-26
-
2022-09-09
Survey response — day 42, dose 2, under 3MedDRA: Nasopharyngitis — Feeling: GoodFree text: Cold virusMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-29 | Moderna | No |
| 2 | 2022-07-27 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-07-20 | Successful 2022-07-21 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: Viral illness - high fever, fatigue, swollen lymph nodes, cough
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Cold virus
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release